There are no items in your cart
On Sunday 7 March, more than 13 000 people created an expansive ‘sea of pink’ through Brisbane City in the 30th annual RACQ International Women’s Day Fun Run. The event raised a record breaking $1.5 million in support of patients treated for breast cancer at Mater, which will help to fund life-saving research.
This year the event was held on the brand-new COVID-Safe course starting at South Bank and finishing in the Brisbane City Botanic Gardens.
Funds raised from the event enable Mater Chicks in Pink to provide tangible support services for patients undergoing breast cancer treatment at Mater and help fund life-saving research programs at Mater Research, to better understand and treat breast cancer in the future.
Now in its 30th year, the fun run continues to grow in popularity. This year the sea of pink not only made waves throughout Brisbane, but across Australia.
For the first time ever, the event included a ‘Your Fun Run, Your Way’ virtual component, where an additional 3000 people from across Australia took part.
Participants were virtually supported on their challenge to enable them to be part of the Fun Run community, having a unique and interactive experience on the day.
Executive Director, Mater Foundation Andrew Thomas said that the number of people diagnosed with breast cancer each year has been steadily rising.
“A staggering 19 974* people were diagnosed with breast cancer in Australia in the last year alone which is just heartbreaking. One in four women in Queensland diagnosed with breast cancer will be treated at a Mater facility,” Andrew said.
“Funds raised from the RACQ International Women’s Day Fun Run go to Mater Chicks in Pink, who provide tangible support services for people battling breast cancer who are treated at Mater; however, the majority goes towards breast cancer research.
“Mater Research is at the forefront of breast cancer research in this country, with some of our scientists making remarkable advances while collaborating with prestigious institutions around the world.”
Principal Research Fellow at Mater Research, and Lead Researcher of the Cancer Immunotherapies Group, Associate Professor Kristen Radford has been working on a new cancer vaccine, which has shown promising signs in preclinical laboratory studies.
“We are hoping this vaccine could be used to treat blood cancers, plus solid malignancies including breast, lung, renal, ovarian, and pancreatic cancers, and glioblastoma,” A/Prof Radford said.
“The team have developed a new vaccine, comprised of human antibodies fused with tumour-specific protein, and are investigating its capacity to target human cells while activating the memory of the tumour cells.
“We hope our continued work towards finding a safe and effective cancer vaccine will benefit cancer patients in the future.”
There is still time to show your support by donating to the RACQ International Women’s Day Fun Run here.
View highlights from this year's event below!